Global Blood Grouping Reagents Market 2020-2024 | Evolving Opportunities with Bio-Rad Laboratories Inc. and DIAGAST | Technavio
LONDON--(BUSINESS WIRE)--Dec 17, 2019--
The global blood grouping reagents market is expected to grow by USD 443.28 million during 2020-2024, according to the latest market research report by Technavio, progressing at a CAGR of over 10%. The growth of the market can be attributed to factors such as the increasing prevalence of chronic disorders, rise in blood donations, and the demand for blood transfusions and blood group typing. Request a free sample report
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191217005308/en/
Technavio has announced its latest market research report titled global blood grouping reagents market 2020-2024. (Graphic: Business Wire)
The market research segments the blood grouping reagents market by end-users (hospitals and blood banks, clinical laboratories, and academic and research institutes)and bygeography (Asia, Europe, North America, and ROW).
Blood Grouping Reagents Market End-Users Outlook (Revenue, USD Million, 2020-2024)
• Hospitals and blood banks
• Clinical laboratories
• Academic and research institutes
Hospitals and blood banks will be the major end-users for blood-grouping reagents during the forecast period. Blood grouping agents are widely used in emergency departments, urgent care centers, and ICUs of hospitals. The increase in the number of hospitals and clinics is the critical factor driving the growth of the segment. The emergence of social media has also fostered the growth of the segment. For instance, in 2017, Facebook partnered with various blood donation centers across the world to increase the number of blood donors. Such initiatives are boosting the growth of the market.
Register for a free trial today and gain instant access to 17,000+ market research reports.Technavio’s SUBSCRIPTION platform
Blood Grouping Reagents Market Regional Outlook (Revenue, USD Million, 2020-2024)
• North America
The North American region led the bleeding disorder market in 2019, followed by Europe, Asia, and ROW. During the forecast period, North America is expected to retain its position as the largest market for blood-grouping reagents. This is due to the growing prevalence of chronic conditions and various types of cancer in the region. Also, the strong presence of vendors in the US is ensuring the easy availability of a wide range of products, which is contributing to the growth of blood-grouping reagents market in North America.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Blood-Grouping Reagents Companies:
Bio-Rad Laboratories Inc., DIAGAST, Grifols SA, Immucor Inc., and Merck KGaA are among the vendors who have a strong position in the global market.
Bio-Rad Laboratories Inc.
Bio-Rad Laboratories Inc. operates its business in the Life science and Clinical diagnostics segments. Seraclone ABO/Rh reagents, Biotestcell Reagent Red Blood Cells, and Rare antisera are some of the key offerings of the company.
DIAGAST operates its business in the Reagents and Automated systems segments. ABD PAD is one of the key offerings of the company. It is a ready-to-use pad based on the latest technology, M-TRAP, which needs only three steps to perform a blood group test within 30 seconds in a safe and standardized manner.
Grifols SA operates the business across segments such as Bioscience, Diagnostic, Hospital, Bio supplies, and Others. Some of the essential products offered by the company include Conventional Serology Reagents, MDmulticard, and BLOODchip ID.
Immucor Inc. operates its business through the Unified business segment. The company offers a wide range of blood grouping and typing reagents. These reagents include the complete product line of traditional antisera, consisting of the routine ABO groups to a monoclonal Anti-P1 and rare lectins.
Merck KGaA operates its business across segments such as Healthcare, Life Science, and Performance materials. BIOSCOT Blood Typing Reagents is one of the key offerings. These reagents are used for blood group typing and are compliant with the requirements of the European Directive.
Technavio provides a free sample report which contains multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.Request a free sample report
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191217005308/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: SCIENCE RESEARCH PHARMACEUTICAL SURGERY GENERAL HEALTH HEALTH HOSPITALS OTHER HEALTH
SOURCE: Technavio Research
Copyright Business Wire 2019.
PUB: 12/17/2019 08:30 AM/DISC: 12/17/2019 08:30 AM